JPRN-UMIN000000514
Completed
Phase 4
Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast Cancer - Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast Cancer (SAFE program: Saitama Anastrozole related Fracture Evaluation program)
Saitama Breast Cancer Clinical Study Group (SBCCSG)0 sites350 target enrollmentNovember 6, 2006
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Hormone-responsive postmenopausal breast cancer
- Sponsor
- Saitama Breast Cancer Clinical Study Group (SBCCSG)
- Enrollment
- 350
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Active multiple cancer (simultaneous multiple cancer, and multi\-organ invasive cancer with less than 5years of event\-free survival) 2\. Non\-invasive cancer, inflammatory breast cancer 3\. Patients with history of osteoporosis or BMD is osteoporosis level (less than 70% of young adult mean (YAM)) 4\. Patients being treated with bisphosphonate drugs or other osteoporotic drugs 5\. Patients diagnosed as having a history of spinal fracure in X\-ray or other imagin tests 6\. Serious complications (hepatic, renal, cardiac, and endocrine diseases, etc.) 7\. Patients with a history of hypersensitivity to any of the ingredients of the study drug 8\. Patients judged to be ineligible for participating in the study by investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
Recruiting
Not Applicable
Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancerJPRN-jRCT1060220042Hirahara Noriyuki45
Active, not recruiting
Phase 1
Evaluation of postoperative administration of tranexamic acid on reducing blood loss after hip prothesis surgery.surgery for hip prosthesis or for hip prosthesis replacementMedDRA version: 18.0Level: LLTClassification code 10044088Term: Total hip replacementSystem Organ Class: 100000004865Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2013-000791-15-FRCHU de Saint-Etienne168
Completed
Phase 1
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.Pancreatic cancerJPRN-UMIN000004332Tokyo Women's Medical University20
Recruiting
Phase 2
A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cellCompletely resected pathologic stage II-IIIA non-small cell lung cancerJPRN-UMIN000002592DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE40